AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Exploring the potential of a new class of drug candidates
The Drug Discovery World Podcast
Introduction
Exploring Vycor Pharma's unique approach to developing angio-tenson II-type II receptor agonists for treating idiopathic pulmonary fibrosis and rare respiratory diseases, highlighting the CEO's insights on the clinical pipeline and potential impact on improving patients' quality of life.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode